Substance Misuse and Substance-Related Disorders in Forensic Psychiatry

Psychiatric Clinics of North America

Volumn 29, Issue 3, 2006, Pages 649-673

  Gendel, Michael H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; BUPRENORPHINE; DISULFIRAM; LEVACETYLMETHADOL; METHADONE; NALOXONE;

ALCOHOLISM; BEHAVIOR; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BIOLOGY; CHILD ABUSE; CIVIL RIGHTS; CLINICAL ASSESSMENT; CLINICAL PRACTICE; COGNITIVE THERAPY; COMPETENCE; COMPULSION; CRIMINAL LAW; CUSTODY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; DRUG DEPENDENCE; FAMILY THERAPY; FETUS OUTCOME; FORENSIC PSYCHIATRY; HUMAN; LEGAL ASPECT; LEGAL LIABILITY; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL RESEARCH; MENTAL DEFICIENCY; MENTAL DISEASE; NEUROLOGY; OPIATE ADDICTION; PHYSICIAN ATTITUDE; PREGNANCY; PRIORITY JOURNAL; PRISON; PROFESSIONAL COMPETENCE; PROFESSIONAL SECRECY; PSYCHIATRIST; RESPONSIBILITY; REVIEW; SELF CONCEPT; SOCIAL ASPECT; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ALCOHOLISM; CIVIL RIGHTS; COMMITMENT OF MENTALLY ILL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EXPERT TESTIMONY; FORENSIC PSYCHIATRY; HUMANS; INSANITY DEFENSE; MENTAL COMPETENCY; SOCIAL RESPONSIBILITY; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 33746856853     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2006.04.010     Document Type: Review

References (66)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th edition, text revision (2000), American Psychiatric Association, Washington (DC)
2. Leshner A.I. Drug abuse and addiction treatment research: the next generation. Arch Gen Psychiatry 54 8 (1997) 691-694
3. Weiss R., and Collins D. Substance abuse and psychiatric illness. Am J Addict 1 2 (1992) 93-99
4. Verebey K.G., Meehan G., and Buchan B.J. Diagnostic laboratory: screening for drug abuse. In: Lowinson J.H., Ruiz P., Millman R.B., et al. (Eds). Substance abuse: a comprehensive textbook. 4th edition (2005), Lippincott Williams & Wilkins, Philadelphia 564-577
5. Volkow N.D., Fower J.S., and Want G.-J. The addicted human brain: insights from imaging studies. J Clin Invest 111 10 (2003) 1444-1451
6. Stirckland T.L., Mena I., Villanueva-Meyer J., et al. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci 5 4 (1993) 419-427
7. Medical Practices Act. Colorado Revised Statutes. §§ 12-36-117, 118 (amended 1995).
8. Wesson D.R., Smith D.E., Ling W., et al. Sedative-hypnotics. In: Lowinson J.H., Ruiz P., Millman R.B., et al. (Eds). Substance abuse: a comprehensive textbook. 4th edition (2005), Lippincott Williams & Wilkins, Philadelphia 307-309
9. Kalavas P.W., and Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiat 162 8 (2005) 1403-1413
10. Hyman S.E. Addiction: a disease of learning and memory. Am J Psychiatry 162 (2005) 1414-1422
11. Bonnie R.J. Responsibility for addiction. J Am Acad Psychiatry Law 30 3 (2002) 405-413
12. Robinson v California, 370 US 660 (1962).
13. Powell v Texas, 392 US 514 (1968).
14. Montana v Egelhoff, 116 S.Ct. 2013 (1996).
15. Metzner J.L., and Buck J.B. Psychiatric disability determinations and personal injury litigation. In: Rosner R. (Ed). Principles and practice of forensic psychiatry (2003), Arnold, London 672-684
16. Dilts S.L., and Gendel M.H. Substance use disorders. In: Goldman L.S., Myers M., and Dickstein L.J. (Eds). The handbook of physician health (2000), American Medical Association, Chicago 118-137
17. Menk E.J., Baumgarten R.K., Kingsley C.P., et al. Success of reentry into anesthesiology training programs by residents with a history of substance abuse. JAMA 263 (1990) 3060-3062
18. Beckson M., Bartzokis G., and Weinstock R. Substance abuse and addiction. In: Rosner R. (Ed). Principles and practice of forensic psychiatry (2003), Arnold, London 672-684
19. Traynor and McKelvey v Turnage, 485 US 539 (1988).
20. Americans with Disabilities Act, 42 USC §§12101 et seq. (1990).
21. Gold L.H. The workplace. In: Simon R.I., and Gold L.H. (Eds). Textbook of forensic psychiatry (2004), American Psychiatric Publishing, Inc., Washington (DC) 303-328
22. Westreich L.M. Addiction and the Americans with Disabilities Act. J Am Acad Psychiatry Law 30 3 (2002) 355-363
23. Burglass M.E. Foresnics. In: Lowinson J.H., Ruiz P., Millman R.B., et al. (Eds). Substance abuse: a comprehensive textbook. 4th edition (2005), Lippincott Williams & Wilkins, Philadelphia 1300-1316
24. Kermani D.J., and Castaneda R.C. Psychoactive substance use in forensic psychiatry. Am J Drug Alcohol Abuse 22 1 (1996) 17-19
25. Dusky v United States, 362 US 402 (1960).
26. M'Naghten's Case, 8 Eng. Rep. 718, 722 (1843).
27. Model Penal Code, sec. 401.1(1) (tentative draft 4) (1955), American Law Institute, Washington (DC)
28. People v Kelly, 10 Cal.3d 565, 516 P2d 875, 111 Cal.Rptr. 171 (1973).
29. Pandina R.J. Idiosyncratic alcohol intoxication: a construct that has lost its validity?. In: Schlesinger L.B. (Ed). Explorations in clinical psychopathology: clinical syndromes with forensic implications (1996), Charles C. Thomas, Springfield (IL) 142-148
30. Resnick P.J., and Noffsinger S. Competency to stand trial and the insanity defense. In: Simon R.I., and Gold L.H. (Eds). Textbook of forensic psychiatry (2004), American Psychiatric Publishing, Inc., Washington (DC) 303-328
31. Weinstock R.W., Leong G.B., and Silva J.A. California's diminished capacity defense: evolution and transformation. Bull Am Acad Psychiatry Law 24 (1996) 347-366
32. Merikangas J. Commentary: alcoholic blackout-does it remove mens rea?. J Am Acad Psychiatry Law 32 (2004) 375-377
33. Granacher Jr. R.P. Commentary: alcoholic blackout and allegation of amnesia during criminal acts. J Am Acad Psychiatry Law 32 (2004) 371-374
34. McKnight v State, SC Sup Ct No. 25585 (2003).
35. Whitner v State, SC Sup Ct No. 24468 (1996).
36. nd 777 (SC 1997).
37. SC Code Ann. § 6-3-85(A) (2003).
38. Sikich K. Peeling back the layers of substance abuse during pregnancy. DePaul J Health Care Law L (2005) 369
39. Kouri E.M., Pope H.G., Powell K.F., et al. Drug use history and criminal behavior among 133 incarcerated men. Am J Drug Alcohol Abuse 23 3 (1997) 413-419
40. Sinha R., and Easton C. Substance abuse and criminality. J Am Acad Psychiatry Law 27 4 (1999) 513-523
41. Gossop M., Trakeada K., Sterward D., et al. Reductions in criminal convictions after addiction treatment: 5-year follow-up. Drug Alcohol Depend 79 3 (2005) 295-302
42. Wald H.P., Flaherty M.T., and Pringle J.L. Prevention in prisons. In: Ammerman R.T., Ott P.J., and Tarter R.E. (Eds). Prevention and societal impact of drug and alcohol abuse (1999), Erlbaum, Mahwah (NJ) 369-381
43. Miller N.S., and Flaherty J.A. Effectiveness of coerced addiction treatment (alternative consequences): a review of the clinical research. J Subst Abuse 18 (2000) 9-16
44. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Substance abuse treatment in adult and juvenile correctional facilities, 2000. Available at: http://www.oas.samhsa.gov/UFDS/CorrectionalFacilities97/hilite_m.htm.
45. Peters R. Substance abuse services in jails and prisons. Law Psychol Rev 17 (1993) 85-116
46. Metzner J.L., and Dvoskin J.A. Psychiatry in correctional settings. In: Simon R.I., and Gold L.H. (Eds). Textbook of forensic psychiatry (2004), American Psychiatric Publishing, Inc., Washington (DC) 303-328
47. Pelissier B., Wallace S., O'Neil J.A., et al. Federal prison residential drug treatment reduces substance use and arrests after release. Am J Drug Alcohol Abuse 27 2 (2001) 315-337
48. Wexler H., Falkin G.P., Lipton D.S., et al. Outcome evaluation of a prison therapeutic community for substance abuse treatment. In: Leukefeld C., and Tims F.D. (Eds). Drug abuse treatment in prisons and jails (1992), US Department of Health and Human Services, Rockville (MD) 71-92
49. Edens J.F., Peters R.H., and Hills H.A. Treating prison inmates with co-occurring disorders: an integrative review of existing programs. Behav Sci Law 15 (1997) 439-457
50. Gendel M.H. Treatment adherence among physicians. Primary Psychiatry 12 6 (2005) 48-54
51. Anfang S.A., Faulkner L.R., Fromson J.A., et al. The American Psychiatric Association's resource document on guidelines for psychiatric fitness-for-duty evaluations of physicians. J Am Acad Psychiatry Law 33 1 (2005) 85-88
52. US Department of Health and Human Services. The mandatory guidelines for federal workplace drug testing programs: final guidelines (1988), US Department of Health and Human Services, Washington (DC)
53. Moos R.H., and Moos B.S. Paths of entry into Alcoholics Anonymous: consequences for participation and remission. Alcohol Clin Exp Res 29 10 (2005) 1858-1868
54. Humphreys K., Moos R.H., and Cohen C. Social and community resources and long-term recovery from treated and un-treated alcoholism. J Stud Alcohol 58 (1997) 231-238
55. Chappel J.N., and DuPont R.L. Twelve-step and mutual-help programs for addictive disorders. Psychiatr Clin North Am 22 2 (1999) 425-446
56. Romelsjo A., Palmstierna T., Hansagi H., et al. Length of outpatient addiction treatment and risk of rehospitalization. J Sust Abuse Treat 28 3 (2005) 291-296
57. McLellan A.T., McKay J.R., Forman R., et al. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction 100 4 (2005) 447-458
58. Zhang Z., Friedman P.D., and Gerstein D.R. Does retention matter? Treatment duration and improvement in drug use. Addiction 98 5 (2003) 673-684
59. McLellan A.T., Grissom G.R., Zanis D., et al. Problem-service "matching" in addiction treatment: a prospective study in four programs. Arch Gen Psychiatry 54 8 (1997) 730-735
60. Woody G.E. Research findings on psychotherapy of addictive disorders. Am J Addict 12 Suppl 2 (2003) S19-S26
61. Weiss R.D., Jaffee W.B., de Menil V.P., et al. Group therapy for substance use disorders: what do we know?. Harvard Rev Psychiatry 12 6 (2004) 339-350
62. Glanz M., Klawansky S., McAullife W., et al. Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction. A meta-analysis of the randomized, controlled trials. Am J Addict 6 4 (1997) 339-349
63. Manlandro J.J. Buprenorphine for office-based treatment of patients with opioid addiction. J Am Osteopath Assoc 105 6 Suppl. 3 (2005) S8-S13
64. Fiellin D.A., Kleber H., Trumble-Hejduk J.G., et al. Consensus statement on office-based treatment of opioid dependence using buprenorphine. J Subst Abuse Treat 27 2 (2004) 153-159
65. Streeton C., and Whelan G. Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials. Alcohol Alcohol 36 6 (2001) 544-552
66. Garbutt J.C., West S.L., Carey T.S., et al. Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 281 14 (1999) 1318-1325